Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4-5

• Main Authors: Jonathan S. Chávez-Iñiguez (Author), Jose J. Zaragoza (Author), Jahir R. Camacho-Guerrero (Author), Vanessa Villavicencio-Cerón (Author), Rafael Valdez-Ortiz (Author), Ana E. Huerta-Orozco (Author), Gael Chávez-Alonso (Author), Ana E. Oliva-Martinez (Author), Bladimir Díaz-Villavicencio (Author), Clementina E. Calderón-García (Author), Jose D. González-Barajas (Author), Manuel Arizaga-Nápoles (Author), Frida M. De La Vega-Méndez (Author), Juan A. Gómez-Fregoso (Author), Francisco G. Rodríguez-García (Author), Guillermo Navarro-Blackaller (Author), Ramón Medina-González (Author), Luz Alcantar-Vallin (Author), Guillermo García-García (Author)
• Formato: Livro
• Publicado em: Karger Publishers, 2023-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: In patients with chronic kidney disease stages 4 and 5 (CKD stages 4-5) without dialysis and arterial hypertension, it is unknown if the values of systolic blood pressure (SBP) considered in control (<120 mm Hg) are associated with kidney replacement therapy (KRT) and mortality. Met...